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Since thousands of years, plants are used as a source for medicine as they are established to possess a reservoir of 
bioactive compounds. Plants have been considered a great natural source of medicinal properties and can be used as either in 
the form of a pure bioactive compound or as traditional preparations. Plants and soil micro-organisms both have been 
considered as a precursor of therapeutically helpful metabolites because of their natural production of various bioactive 
secondary metabolites. Evolving drug resistance these days increase the need to isolate new drugs for the treatment of many 
diseases caused by multidrug-resistant organisms. To combat these multidrug-resistant pathogens, studies were carried out 
to isolate antibiotic compounds from actinomycetes. In the present study, a total of 65 isolates were isolated from 
rhizospheric actinomycetes. Isolation, characterization and biochemical tests of actinomycetes were carried out and 
subjected to fermentation and solvent extraction by four solvents as- benzene, pet ether, ethyl acetate, and chloroform of 
AIA26 isolate. After extraction crude obtained was checked for their antimicrobial activity on Mueller Hinton agar (MHA) 
media against five indicator organisms but, activity was recorded against S. aureus and P. aeruginosa, and no activity was 
obtained against P. vulgaris, K. pneumonia, and B. subtilis. By the help of GCMS technique, major compounds present have 
been identified in AIA26 isolate. 
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Introduction 
It has been recognized for long that various plants 
and microorganisms have provided noteworthy 
contribution to the development and discovery of 
newer antibacterial drugs. Therefore, plant and 
bacterial crude extracts have been studied in vivo and 
in vitro for past many years against several multi drug-
resistant (MDR) bacteria like P. aeruginosa1,2. Various 
secondary metabolites have been discovered from soil 
organisms which have contributed to the Medical, 
Agriculture and Pharmaceutical industries2. The 
resistance of pathogens against current antibiotics and 
the increasing burden of infectious diseases is a matter 
of concern. There is a vast potential for natural 
product-based discovery and development of drug 
candidates with good therapeutic efficacy and low 
toxicity3. In the region of the rhizosphere, plants and 
microorganisms live together to make an extraordinary 
biological community; which involves activity like 
carbon and water cycling, supplement and mineral 
trapping etc. Taking into consideration, the plant-
microbes association, their cooperation produces a 
broad scope of bioactive metabolites, which are 
amazingly significant and are known to encourage 
different purposes. The actinomycetes, primarily those 
belonging to Streptomyces sp., make up a large 
significant group of soil microorganisms and are 
excellent in the degradation of complex molecules to 
basic or simple substances for plant development and 
promotion and control plant pathogens4. There are 
plenty of compounds which have been isolated and 
characterized, many of which have been developed into 
drugs for various treatment of broad range of diseases 
in human, veterinary, and agriculture sectors5. For this 
reason, the actinomycetes have been considered to be 
the most powerful source for the production of 
secondary metabolites, antibiotic drugs and other 
bioactive compounds. There is substantial evidence 
confirming that actinomycetes are remarkable as an 
antibiotic and other active metabolites producers, 
making 75% of all well-known products, and the 
Streptomyces has an exceptional role in antibiotic 








persist to be valuable sources of novel bioactive 
secondary metabolites with a broad range of biological 
performance which may ultimately find applications as 
anti-infectious, anticancer agents and other 
pharmaceutically helpful compounds6. There are yet 
many unexplored or uninvestigated regions, which 
require to be investigating for novel active compounds. 
Since emergence and re-emergence of (MDR) multi 
drug resistant pathogenic organisms, there is a 
necessity to expand additional powerful antimicrobial 
metabolites with wide-spectrum antimicrobial  
activity. Hence, the actinomycetes were grown for  
the production of antimicrobial metabolites using 
Actinomycetes Isolation Agar (AIA) media. 
 
Materials and Methods 
Rhizospheric sample collection  
For the collection of samples, four rhizospheric 
regions of Rajasthan were selected like Kota, Jaipur, 
Alwar, and Udaipur. Samples were collected with dried, 
clean hand gloves and debris was removed from samples 
and transferred it to sterile covers. Around 12-15 cm, 
deep rhizospheric samples were taken and brought to 
Research laboratory of JECRC University, Jaipur, 
Rajasthan. Presence of moisture was removed from 
samples by keeping them at room temperature for 24-48 
hours. Each sample was stored at 4 oC till further 
processing7. Samples were processed by drying, 
crushing and sieving for starting the isolation  
process. After air-drying at room temperature, dried  
soil was crushed into motor and pestle. Thereafter,  
the soil was sieved through a plastic sieve (2-3 times) 
and passed samples were collected for further process8. 
 
Isolation and maintenance of actinomycetes 
Isolation of actinomycetes AIA26 isolate was 
carried out with 1 g of dry soil sample which was 
suspended in 9 mL of sterile distilled water and mixed 
well. Dilutions were prepared up to 10-5. Prepared 
dilutions of 10-1, 10-2, 10-3, 10-4, and 10-5 were 
spread on the Petri plates containing autoclaved AIA 
medium. ‘L’ shaped glass spreader was used for 
spreading of dilutions on plates filled with AIA 
media. Media plates were incubated inverted at 37 oC 
for 7-14 days. Immediately after the incubation 
period, colonies were selected from the Petri plates 
and re-streaked every colony on AIA media. Pure 
colonies were obtained and stored for further testing9. 
 
Morphological characteristics of the isolate 
Morphological characterizations of the isolated 
colony were carried out using gram’s staining 
method. Twenty four hours old Luria broth culture 
of isolate AIA26 was used for gram’s staining 




Isolate AIA26 was screened for their 
antimicrobial activity against selected indicator 
bacterial cultures. Indicator bacterial cultures were 
brought from IMTECH Chandigarh. Studies were 
conducted on antimicrobial activity of isolate against 
Staphylococcus aureus (MTCC 3160), Pseudomonas 
aeruginosa (MTCC 1688), Klebsiella pneumonia 
(MTCC 432), Proteus vulgaris (MTCC 7306), 
Bacillus subtilis (MTCC 441). The method used for 
the activity tests were both disc diffusion and  
agar well method carried out in the Research 
laboratory of JECRC University Jaipur, Rajasthan. 
These pathogenic bacterial strains were regularly 
maintained in the nutrient agar (NA) media slants for 
routine laboratory use and for long time uses, were 
stored at 4 oC11. 
 
Fermentation and extraction of antibiotics 
For the production of antibiotics or antimicrobial 
compounds, 500 mL of Luria broth was prepared  
and dispersed into 2 flasks of 250 mL and each  
flask was autoclaved for sterilization. Flasks were 
sterilized and inoculated with isolate and kept in  
the shaker incubator at 30 oC at 150 rpm for  
2-3 weeks. After appropriate incubation, the broth 
culture was centrifuged for 20 minutes at 5,000  
rpm for the separation of supernatant and the biomass. 
For the separation of metabolites, four solvents  
were used like Pet ether, Benzene. Ethyl acetate and 
chloroform were used for bioactive components 
extraction from AIA26 culture broth. Each solvent 
and isolate culture was mixed to 1:1 (v/v) amount and 
shaken well for proper mixing. Flasks were kept for  
30 minutes without interruption till two diverse layers 
(organic and inorganic layer) seen were completely 
separated from each other. Beakers with solvent 
(containing bioactive metabolites) were kept on the 
water bath for absolute disappearance of solvents  
at 60 oC and the beaker was then left with secondary 
metabolites2. A mixture of bioactive compounds  
was transferred from beaker to small Eppendorf  
tube for further identification of compounds by Gas 
chromatography Mass spectroscopy (GCMS) 
technique12,13. 




Antibacterial activity against indicator pathogens 
The antibacterial test of AIA26 isolate was carried 
out against S. aureus, P. aeruginosa, K. pneumonia, 
P. vulgaris, and B. subtilis indicator pathogens. 
Inhibition zone (IZ) of antibacterial activity of the 
crude extracts of benzene, pet ether, ethyl acetate, 
chloroform was measured. Petri-plates were prepared 
with 20 mL of Mueller Hinton Agar (MHA) media 
and indicator strains were spread on the solidified 
MHA media and covered plates after holding for  
10 minutes for drying of plates. For the activity test, 
standard Kirby-Bauer disc diffusion and agar well 
diffusion method was used. This activity test was 
conducted with each crude extracts. The sterilized 
discs with crude extract were positioned on the MHA 
media plates and kept for 30 minutes at room 
temperature so that complete diffusion of compounds 
can take place. The plates were incubated overnight at 
30 oC and IZ was measured (mm) against each 
pathogen14,15. 
 
Identification of main bioactive components using GC–MS 
The composition of the crude extracts of AIA26 
isolate was identified by GCMS analysis by Shimadzu 
QP 2010 ultra and gas chromatograph interfaced to a 
mass spectrometer GCMS. The instrument was built 
with Elite-1 fused silica capillary. Helium gas 
(99.99%) was used as carrier gas. Flow rate was set as 
1.21 mL/min and with a split ratio: 10. Injector 
temperature was 260 °C; ion-source temperature  
200 °C. The oven temperature was intended from  
60 °C (constant for 3 minutes) with an increment as  
of 280 °C for 22 minutes. Mass spectra were taken  
at 70 eV; scan time 0.5 seconds. The chemical 
composition of the crude extract was analyzed by 
measurement of the peak area and the retention time 
by NIST 14 library16. 
 
Results and Discussion 
Antimicrobials have been considered crucial for 
medical as well as agricultural purposes. Many 
secondary metabolites have been produced and 
applied as a source of therapeutic drugs for the past 
many years. On the other hand, drug resistance has 
increased and as a result, diverse human diseases have 
risen. With this changing atmosphere and necessity of 
antimicrobials, screening with validation of 
antibiotics in the form of precious drugs needs to be 
updated. Isolation of actinomycetes was carried out 
on AIA media followed by Gram staining and some 
biochemical test like Gelatin liquefaction, Starch 
hydrolysis, Triple sugar iron (TSI) agar, Casein 
hydrolysis, Citrate Utilization, Methyl red, Voges-
Proskauer, Nitrate reduction, Indole production, 
Catalase test, Urease production, Hydrogen sulphide 
production (H2S), Motility test, Mannitol, Lactose, 
Dextrose, Sucrose and Mannose (Table 1) were 
executed with isolate AIA26.  
After biochemical characterization of the pure 
colony, culture broth fermentation process was 
executed. After the incubation period, extraction of 
bioactive components from four selected solvents 
such as pet ether, benzene, ethyl acetate and 
chloroform was completed. The isolate was examined 
for antimicrobial activity against some of the selected 
indicator pathogens. Extraction of components was 
preceded by layer separation method followed by 
sterilization of discs. Discs with compounds were 
applied on prepared plates of MHA media already 
occupied with indicator organisms growth. 
Antimicrobial susceptibility assessment was 
performed against indicator strains S. aureus,  
P. aeruginosa, K. pneumonia, P. vulgaris, and  
B. subtilis procured from IMTECH Chandigarh. IZs 
of antibacterial activity of crude extracts were 
recorded against S. aureus (IZ=Ben-24mm)  
Table 1 — Characterization of AIA26 isolate 
Characteristics  Result 
Gram staining  +ve 
Aerobic growth +ve 
Anaerobic growth -ve 
Sugar fermentation test Gelatin liquefaction  +ve 
Starch hydrolysis -ve 
Triple sugar iron (TSI) agar +ve 
Casein hydrolysis +ve 
Citrate Utilization -ve 
Methyl red -ve 
Voges-Proskauer -ve 
Nitrate reduction -ve 
Indole production -ve 
Catalase test +ve 
Other tests  
Urease production -ve 
Hydrogen sulphide production (H2S) +ve 













P. aeruginosa (IZ=Ben-42 mm), and P. aeruginosa 
(IZ=Chl-18mm) and no activity was recorded against 
P. vulgaris, K. pneumonia and B. subtilis (Fig. 1). 
From analysis obtained from GCMS, Structure, 
Molecular weight, Molecular formula, Retention time 
(RT) and Area percentage of components were 
identified and matched from NIST14 library. Fatty 
acids, phenolic compounds, alkaloids, alcoholic 
compounds and amide compounds etc. were present in 
good to a moderate amount (Table 2). Presence of 
compounds in the crude extract of AIA26 isolated 
colony was characterized by GCMS technique. Major 
compounds obtained in Chloroform extract of AIA26 
isolate, Phenol, 2,4-bis(1,1-dimethylethyl)- at RT- 14.54, 
3-methyl-1,4-diazabicyclo[4.3.0]nonan-2,5-dione, n-
acetyl at RT- 19.539, Pyrrolo[1,2-a]pyrazine-1,4-dione, 
hexahydro-3-(2-methylpropyl) at RT-21.939, 5h,10h-
dipyrrolo[1,2-a:1’,2’-d]pyrazine-5,10-dione, octahydro-, 
(5as-cis)- at RT- 24.121, Acetamide, n-[2-(1h-indol-3-
yl)ethyl]- at RT- 29.21, O o’-biphenol, 4,4’,6,6’-tetra-t-
butyl- at RT- 31.541, Pyrrolo[1,2-a]pyrazine-1,4- 
dione, hexahydro-3-(phenylmethyl) at RT- 31.755,  
1-heptacosanol at RT-31.872, N-tetracosanol-1 at RT- 
28.463, Docosyl heptafluorobutyrate- at RT-39.83.  
A relative concentration of compounds was shown  
by chromatogram of AIA26 isolate (Fig. 2). In 
chromatogram height of every peak showed a 
proportional concentration of compounds present in the 
sample. 
Actinomycetes have potential that produces diverse 
compounds showing a good range activity against the 
selected variety of indicator organisms. 1,2 – Benzene 
dicarboxylic acid, bis (2-methyl propyl) ester 
compound was isolated from chloroform extract of 
Portieria hornemannii (red algae) and leaves of the 
plant Begonia malabarica Lam. B. malabarica Lam. 
is medicinally significant herbs belonging to the 
family of Begoniaceae. Its leaves have been reported 
to be effective in the treatment of respiratory 
infections, diarrhoea, blood cancer, and skin diseases. 
The entire plant has a diverse variety of secondary 
metabolites. 1,2 – Benzene dicarboxylic acid, bis (2-
methyl propyl) ester has antibacterial and anticancer 
activity17,18.   Phenol,  2,   4-bis   (1,1-dimethylethyl) – 
compound has antibacterial and anti-inflammatory 
activity reported in leaves of Nimbapatradi 
Choornam plant. Nimbapatradi Choornam is a well 
known Ayurvedic medicine for various diseases like; 
Leprosy, eczema, gout, leukoderma, skin eruptions 
and psoriasis. The different ingredients of 
Nimbapatradi choornam are neem leaves, sulphur, 
and turmeric, which are used for their antiseptic 
properties19. N-tetracosanol-1 compound was  
isolated from Chloroform extract of the Croton 
bonplandianum leaves. N-tetracosanol-1 has anti-
bacterial activity, nematicidal, anticancer, antioxidant, 
and antimicrobial activity. Croton bonplandianum 
belongs to Euphorbiaceae family and has been used to  
 
 
Fig. 1 — Antibacterial activity of chloroform crude extract of AIA26 isolate 





Table 2 — Composition of chloroform extract, RT, molecular weight and molecular formula of compounds of 
 rhizospheric AIA26 isolate by GCMS analysis 
R.Time Compound name Molecular weight Molecular formula 
14.54 Phenol, 2,4-bis(1,1-dimethylethyl)- 206 C14H22O 
15.466 P-tert-butyl catechol 166 C10H14O2 
15.874 Bis(2,4-dimethylamino)pyrimidine 166 C8H14N4 
16.457 1,2-benzenedicarboxylic acid, didecyl est 446 C28H46O4 
16.935 2-d,2-pentadecyl-1,3-dioxepane 212 C20H39DO2 
17.273 Sedoheptulose, 2,3:4,5-dimethylene- 234 C9H14O7 
19.539 3-methyl-1,4-diazabicyclo[4.3.0]nonan-2,5-dione, n-acetyl 210 C10H14N2O3 
20.291 3,5-di-tert-butyl-4-hydroxybenzaldehyde 234 C15H22O2 
20.696 1-octadecanol 270 C18H38O 
20.829 Eicosane 282 C20H42 
21.939 Pyrrolo[1,2-a]pyrazine-1,4-dione, hexahydro-3-(2-methylpropyl)- 210 C11H18N2O2 
23.551 7,9-di-tert-butyl-1-oxaspiro(4,5)deca-6,9-diene-2,8-dione 276 C17H24O3 
24.121 5h,10h-dipyrrolo[1,2-a:1’,2’-d]pyrazine-5,10-dione, octahydro-, (5as-cis)- 194 C10H14N2O2 
24.323 1,2-benzenedicarboxylic acid, dibutyl ester 278 C16H22O4 
24.797 Octacosanol 410 C28H58O 
25.454 2,4,6-tri-t-butylbenzenethiol 278 C18H30S 
26.283 Cyclopenta[c]pyran-7-carboxaldehyde, 4-[(acetyloxy)methyl]- 218 C12H10O4 
26.468 Benzenebutanoic acid, .alpha.,2-diamino-.gamma.-oxo-, (s)- 208 C10H12N2O3 
27.251 Triacontanoic acid, methyl ester 466 C31H62O2 
28.028 Octadecanoic acid 284 C18H36O2 
28.184 Tetratetracontane 618 C44H90 
28.342 Dodecanoic acid, 3-methylbutyl ester 270 C17H34O2 
28.463 N-tetracosanol-1 354 C24H50O 
29.21 Acetamide, n-[2-(1h-indol-3-yl)ethyl]- 202 C12H14N2O 
31.541 O o’-biphenol, 4,4’,6,6’-tetra-t-butyl- 410 C28H42O2 
31.755 Pyrrolo[1,2-a]pyrazine-1,4-dione, hexahydro-3-(phenylme 244 C14H16N2O2 
31.872 1-heptacosanol 396 C27H56O 
34.742 1,2-benzenedicarboxylic acid 390 C24H38O4 
38.201 2,4,6-trihydroxybenzaldehyde 154 C7H6O4 
39.206 1,2-bis(3,5-di-tert-butyl-4-hydroxyphenyl)-ethylene 436 C30H44O2 
39.83 Docosyl heptafluorobutyrate 522 C26H45F7O2 
40.665 Cycloprop[e]indene-1a,2(1h)-dicarboxaldehyde, 3a,4,5,6, 232 C15H20O2 




Fig. 2 — Chromatogram Chloroform of AIA26 isolate showing 
peaks of compounds in GCMS analysis 
 
cure liver diseases, swelling of the body, ringworms, 
and skin diseases20. Pyrrolo[1,2-a]pyrazine-1,4-dione, 
hexahydro-3-(2-methylpropyl) compound has 
antibacterial and  antifungal  activity  in  ethyl  acetate 
extract isolated from Streptomyces strain. 
Pyrrolo[1,2-a]pyrazine-1,4-dione, hexahydro-3-(2-
methylpropyl) and Pyrrolo[1,2-a]pyrazine-1,4-dione, 
hexahydro-3-(phenylmethyl) have been isolated from 
Epichloe spp. and Neotyphodium spp. Pyrrolo[1,2-
a]pyrazine-1,4-dione, hexahydro-3-(phenylmethyl) 
also has antifungal property in ethyl acetate  
extract isolated from Streptomyces strain21,22. 
Tetratetracontane is an antioxidant compound and  
has cytoprotective activities. Tetratetracontane was 
isolated from the plant Quisqualis indica, commonly 
known as Rangoon creeper belonging to family 
Combretaceae. Some medicinal properties of Q. 
indica L. have been known in Ayurveda. Nearly all of 
the plant parts are used independently or mixed with 
other ingredients as a remedy to different ailments 
like anti flatulence, coughs, diarrhoea, body pains, 
and toothache. Herbs are very rich in flavonoids  
and vitamin C that may enhance immune function. 
The plant Q. indica L.has immunomodulatory, 
antibacterial, antioxidant, antipyretic, anthelmintic, 
antirheumatic, antiviral,  antifungal,  anti- inflammatory,  
 





Table 3 — Components with their biological activity present in chloroform extract of isolate AIA26 
RT Name of Compound Nature of compound Other Sources of compounds Parts/extract Activity 
34.742 1,2 – Benzene dicarboxylic  
acid, bis (2-methyl propyl) ester 
Pale yellow oily  
substance 
Red algae Portieria 
hornemannii 








14.54 Phenol, 2,4-bis 
(1,1-dimethylethyl)- 
Alkylbenzene Nimbapatradi Choornam leaves extract Antibacterial and 
anti-inflammatory 
activities19 










Aromatic compounds Streptomyces strain 









Aromatic compounds Streptomyces strain 










20.829 Eicosane Alkane Streptomyces strain Ethyl acetate 
extract 
Antifungal24 
20.696 1-octadecanol Long chain alcohol Caralluma indica Stem Antibacterial, 
antifungal & anti-
larva25 
27.251 Triacontanoic acid,  
methyl ester 





24.797 Octacosanol Long chain alcohol Sabicea grisea var. grisea Leaves Antinociceptive and 
anti-Inflammatory27 
28.028 Octadecanoic acid Fatty acid Biophytum sensitivum Leaf and callus 
extracts 
Antibacterial28 







anti-staphylococcal, and antiseptic properties23. The 
plant has also been reported to helpful in relief in 
stomach pain, cold, skin parasites, and rickettsia23. 
Eicosane compound has antifungal activity against 
Rhizoctonia solani, which is a causal agent of target 
spot in tobacco and caused serious economic loss 
regarding the production and quality of the tobacco24. 
1-Octadecanol was isolated from the stem of 
Caralluma indica having antibacterial, antifungal, and 
anti-larva properties25. Triacontanoic acid, methyl 
ester compound has antibacterial activity and isolated 
from the plant Gracilaria corticata having medicinal 
properties26. Octacosanol compound isolated from 
Sabicea grisea has antinociceptive and anti-
Inflammatory activity. Sabicea species have been 
used in the treatment of fever and malaria, its 
chemical components help relieve pain and 
inflammation27. Octadecanoic acid has antibacterial 
activity and is reported from the plant Biophytum 
sensitivum. Its leaf and callus extracts have potent 
antibacterial actions. B. sensitivum known as life plant 
has many medicinal properties such as it helps in 
reducing diabetes, is effective in the treatment of 
inflammatory diseases, and has antiseptic properties28. 
1-Heptacosanol has nematicidal, anticancer, 
antioxidant, and antimicrobial activity and was 
isolated from Eupatorium odoratum (Asteraceae). 
The plant has been used for the treatment of various 
microbial diseases29 (Table 3). 
 
Conclusion 
The present study showed that rhizospheric soil 
actinomycetes have the capability of producing 
antimicrobial compounds exhibiting antibacterial 
activity against selected pathogens. A good 
antibacterial activity (24 and 42 mm) was found 
against pathogen S. aureus and P. aeruginosa from 
benzene crude extract. GCMS analysis showed the 




presence of a diverse group of bioactive compounds. 
Chloroform extract showed various compounds 
important as antimicrobials. These compounds have 
importance in agricultural and medical sector and are 
significant in biotechnological purposes. Inhibition 
zones of antibacterial activity of the chloroform 
extract of actinomycetes isolate against the multi drug 
resistant pathogens were realized. The unexplored 
rhizospheric regions of Rajasthan actinomycetes is the 
source for the revival of bioactive secondary 
metabolites with an extensive amount of activities that 
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